Dr. Jain will provide leadership to the Genetic Therapies Working Group (GTWG). The GTWG is composed of people with various expertise who will try to develop guidance for bio-pharmaceutical companies on how genetic therapies should be developed for CF patients.
|Effective start/end date||4/1/21 → 3/31/22|
- Cystic Fibrosis Foundation (JAIN21A0-LAD)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.